Sociodemographic and clinical characteristics of patients with Kaposi sarcoma: Characterization of early-onset disease in a serial cross-sectional Study, 2010-2022

Figure 1 A/B. Sankey Diagrams Illustrating Treatment Pathways and Clinical Characteristics in Kaposi sarcoma (KS). (A, left) KS subgroups (Classic KS, Early-Onset KS, and HIV-associated KS by CD4 strata) and the treatment modalities they received. (B, right) Treatment modalities (None, Chemotherapy, Local Therapy, ART Only, Stop Immunosuppressant) and their association with clinical outcomes (Progression, Stable, Resolution). Treatment options with less than 5 counts not included in the sankeyplot.